Anavex Life Sciences Corp — Cash Flow (NASDAQ:AVXL) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -21.29 M-30.38 M-24.24 M27.79 M30.81 M39.04 M 34.08 M Cash from investing activities —————-40.3 M — Cash from financing activities 28.35 M153.24 M21.29 M29.65 M11.97 M9.43 M 45.05 M Free cash flow -21.29 M-30.38 M-24.24 M27.79 M30.81 M36.34 M 34.08 M

Notícias

Anavex Life Sciences nomeia Dr. Axel Paeger para conselho

Anavex Life Sciences appoints Dr. Axel Paeger to board

Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?

Anavex: Negative EU Opinion Leaves Blarcamesine In Regulatory Purgatory (NASDAQ:AVXL)

Anavex Life Sciences supera previsão de LPA no 1º tri de 2026

Earnings call transcript: Anavex Life Sciences beats EPS forecast in Q1 2026

Anavex Stock And Alzheimer's Disease: The Future Never Seems To Be Now (NASDAQ:AVXL)

H.C. Wainwright reiterates Buy rating on Anavex Life Sciences stock

Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Anavex nomeia Wolfgang Liedtke como vice-presidente sênior de neurologia

Anavex appoints Wolfgang Liedtke as SVP of neurology